SEC Form 4 · accession 0000919574-26-004021

Eloxx Pharmaceuticals, Inc. · ELOX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Domicilium Real Estate Fund III LP

10% Owner

Period of report

Jun 10, 2026

Accepted (ET)

Jun 17, 2026 · 5:15 pm EDT

Rule 10b5-1 plan

box not checked

Issuer CIK

0001035354

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
common stock, $0.01 par value per share^F1,F2	Jun 10, 2026	J	238,422	—	A	238,422	I	See footnote
common stock, $0.01 par value per share^F1,F3	Jun 10, 2026	J	361,578	—	A	361,578	I	See footnote
common stock, $0.01 par value per share^F4	holding	—	—		—	14,285	I	See footnote

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Pre-funded Warrant^F5,F2	—	Jun 10, 2026	J	238,422	A	—	—	common stock, $0.01 par value per share	238,422	0	I
Pre-funded Warrant^F5,F3	—	Jun 10, 2026	J	361,578	A	—	—	common stock, $0.01 par value per share	361,578	834,489	I
Pre-funded Warrant^F6,F5	—	holding	—	—	—	—	—	common stock, $0.01 par value per share	0	361,578	I
Pre-funded Warrant^F7,F5	—	holding	—	—	—	—	—	common stock, $0.01 par value per share	0	611,317	I

Explanation of responses

F1Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock.
F2The securities are owned directly by Domicilium Real Estate Fund III LP (the "Fund") and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium"), the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (ii) Daniel Simon, the managing member of Domicilium and the General Partner.
F3The securities are owned directly by BKJLAGG, LLC ("BKJLAGG") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to BKJLAGG, and (ii) Daniel Simon, the managing member of Domicilium.
F4The securities may be deemed to be indirectly beneficially owned by (i) Domicilium, and (ii) Daniel Simon, the managing member of Domicilium.
F5The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
F6The securities are owned directly by MSEK Charleston LLC ("MSEK") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to MSEK, and (ii) Daniel Simon, the managing member of Domicilium.
F7The securities are owned directly by Bold Stroke Investments, LLC ("Bold Stroke") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to Bold Stroke, and (ii) Daniel Simon, the managing member of Domicilium.

Remarks

Domicilium Capital Partners LLC, Domicilium Real Estate Fund III GP LLC, Daniel Simon, BKJLAGG, LLC, MSEK Charleston LLC and Bold Stroke Investments, LLC will be reported as a Reporting Person on a subsequent Form 4 once CIK codes are received. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.